CDH2 and non-small cell lung carcinoma: Furthermore, the disruption of folate integrity in NSCLC cells can also lead to the overexpression of EMT biomarkers, including SLUG and N-cadherin, a pair of newly discovered effectors that cause resistance to gefitinib [26,31].